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Abstract
In recent years, there has been a move away from the use of static in vitro 2D cell culture mod-
els for testing the chemical safety and efficacy of drugs. Such models are increasingly being
replaced by more physiologically relevant cell culture systems featuring dynamic flow and/or
3D structures of cells. Whilst it is acknowledged that such systems provide a more realistic
environment within which to test drugs, progress is being hindered by a lack of understand-
ing of the physical and chemical environment that the cells are exposed to. Mathematical and
computational modelling may be exploited in this regard to unravel the dependency of the cell
response on spatiotemporal differences in chemical and mechanical cues, thereby assisting with
the understanding and design of these systems. In this paper, we present a mathematical mod-
elling framework that characterises the fluid flow and solute transport in perfusion bioreactors
featuring an inlet and an outlet. To demonstrate the utility of our model, we simulated the fluid
dynamics and solute concentration profiles for a variety of different flow rates, inlet solute con-
centrations and cell types within a specific commercial bioreactor chamber. Our subsequent
analysis has elucidated the basic relationship between inlet flow rate and cell surface flow speed,
shear stress and solute concentrations, allowing us to derive simple but useful relationships that
enable prediction of the behaviour of the system under a variety of experimental conditions,
prior to experimentation. We describe how the model may used by experimentalists to define
operating parameters for their particular perfusion cell culture systems and highlight some op-
erating conditions that should be avoided. Finally, we critically comment on the limitations of
mathematical and computational modelling in this field, and the challenges associated with the
adoption of such methods.
Keywords
3D cell culture, bioreactor, mathematical and computational modelling, fluid dynamics, mass
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1 Introduction
Drug discovery is a long and expensive process, with the development of a single drug taking
many years to complete and the cost increasing significantly at each stage of testing [1, 2]. In
addition, regulation states that animal usage in drug testing must be minimised or avoided [3].
Therefore, it is critical that the drug discovery process is as efficient as possible in order to
develop drugs quickly whilst lowering costs and reducing the use of animals.
The first stage of drug development is to identify and optimise lead compounds to create
potential drug molecules. Properties such as absorption, metabolism and toxicity are tested
in preclinical studies (in vitro cell-based and in vivo animal-based experiments) before human
clinical trials take place prior to marketing and approval of the drug. In order to maximise
the efficiency of the screening process, drugs which are likely to fail need to be eliminated
as early as possible. In vitro experiments conducted at the initial stages of testing are often
poorly representative of the in vivo environment since cells are typically cultured under static
conditions in a two-dimensional (2D) array, whereas in reality, cells in three-dimensional (3D)
configurations are able to communicate with other cells whilst being exposed to flow. Animal
studies are unethical, costly and often poorly predictive of the human response due to species
differences. Thus, it is essential that new drug testing systems are developed which do not
involve (or limit the use of) animals and which reflect the physiological environment so that
drugs likely to fail will be eliminated earlier in the screening process [1, 2].
Mathematical modelling can be useful in the design and optimisation of novel drug testing
systems. For example, prototypes of new devices can be built virtually and features such as ge-
ometry can be easily modified allowing the ‘best’ design to be chosen prior to fabrication of the
device. Despite the fact that experiments are usually run with constant inlet solute concentra-
tions (e.g. oxygen (O2), drug, nutrients) and flow rates, spatial gradients and time-dependencies
in solute concentrations and fluid forces (shear stress) often emerge, meaning that cells are not
exposed to a homogeneous environment. Mathematical and computational modelling may be
exploited in this regard to unravel the dependency of the cellular response on spatiotemporal dif-
ferences in chemical and mechanical cues, thereby assisting with the understanding and design
of these systems. A range of suitable operating parameters can then be established depending on
the desired experimental outcome, allowing for the accurate configuration of devices with less
reliance on a ‘trial and error’ approach.
Perfusion bioreactors are dynamic cell culture systems which have been gaining much at-
tention in recent years. These systems allow cells to be cultured in 2D and 3D configurations
whilst being exposed to flow. Improved cell viability and metabolic function has been observed
under cell culture conditions provided by bioreactors: the presence of flow provides a supply of
nutrients to the cells, co-culture promotes cell-cell interactions and cells cultured in 3D config-
urations are able to retain their physiological morphology [4].
There are a number of existing studies in the literature which use mathematical modelling to
characterise certain perfusion bioreactors. For example, models of fluid flow and solute trans-
port have been employed to optimise chamber design [5], design a gradient generator for drug
toxicity testing [6], predict concentration gradients [7] and maximise mass transfer whilst con-
trolling shear stress levels [8]. Other studies have adopted multiphase approaches to investigate
the effect of flow on tissue growth [9] and elucidate the relationship between shear stress and
cell yield and distribution within hollow-fibre bioreactors [10]. A comprehensive review of con-
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tinuum modelling approaches in artificial scaffolds and bioreactors more generally, covering
cell population dynamics, the cell’s mechanical environment and cell-environment interactions,
within a multiphase framework, may be found in [11]. Most relevant to this study, a model
was developed to optimise the design of a modular bioreactor chamber [12] and to assess if the
O2 delivery and shear stress levels would be acceptable for the culture of hepatocytes within a
hydrogel layer [13]. More recently, models were developed to predict flow patterns, O2 trans-
port and test compound distribution within three different bioreactors to identify which of the
systems would be most suitable for long-term culture of hepatocytes within alginate beads [14].
A key limitation of these existing models is that they account for very specific experiments and
cell types (e.g. culturing hepatocytes within a hydrogel layer or alginate beads). Since perfu-
sion bioreactors are increasingly being used for a variety of applications incorporating different
cell types and solutes with different mechanisms of action, it is important to consider potential
differences in the environment and operating conditions.
The primary purpose of this paper is to provide mathematical and computational models
and results that can assist with the design and operation of advanced cell culture systems. In
addition, we aim to highlight potential barriers to the adoption of in silico models in this field.
We present a more general modelling framework that characterises the fluid flow and solute
transport in perfusion bioreactors featuring an inlet and an outlet. We start by presenting the
model equations, as well as initial and boundary conditions that describe the environment within
an arbitrary bioreactor chamber. We consider two common types of solute reaction with the cells
- nonlinear saturable binding and Michaelis-Menten (M-M) kinetics - and we use mathematical
arguments to justify simplifications of the underlying equations in certain cases. We then provide
simple relationships which allow for the rapid prediction of cell surface solute concentration
profiles in single and connected chambers, prior to experimentation. To demonstrate the utility of
our model, we simulate the fluid dynamics and solute concentration profiles for a variety of input
flow rates, inlet concentrations and cell types within a specific bioreactor chamber: the Kirkstall
QV900. For single and connected chambers, we examine the relationships between input flow
rate and cell surface flow speeds, shear stress levels and solute concentrations and investigate
the effect of varying cell-specific parameters on solute concentration profiles at the cell surface.
Finally, we critically comment on the limitations of mathematical and computational modelling
in this field, and the challenges associated with the adoption of such methods.
2 Mathematical and computational methods
We begin by considering an arbitrary geometry to represent a bioreactor chamber featuring an
inlet and an outlet, assuming that cells are cultured at the base of the chamber either in a 3D
region or within a monolayer. We note that the model is applicable to any chamber geometry
with these properties. Fig. 1 illustrates how we set up the model equations to describe fluid flow
and solute transport and this will be discussed in detail in the following text.
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Figure 1: Schematic drawing of an arbitrary bioreactor geometry featuring an inlet and an outlet with
cells cultured at the base of the chamber to illustrate the model set-up. For full details of the equations,
the reader is referred to the text.
2.1 Fluid dynamics in the chamber
Assuming we have an incompressible Newtonian fluid, the flow velocity and pressure are de-
scribed using the continuity and Navier-Stokes equations:
∇ · u = 0, (1)
ρ
∂u
∂t
+ ρ(u · ∇)u = −∇p+ µ∇2u, (2)
where u (m s−1) is the velocity field, p (Pa) is the pressure, ρ (kg m−3) is the fluid density and
µ (Pa s) is the dynamic viscosity. Initially, the fluid velocity is zero (u = 0) in the chamber. At
the inlet, we assume a normal inflow parabolic velocity profile with magnitude derived from the
volumetric flow rate, Q, which can be controlled in experiments (see Supplementary Material).
We assume zero pressure (p = 0) at the outlet and no slip and no penetration conditions (u = 0)
are imposed on all interior walls.
2.2 Solute transport in the chamber
The transport of each solute through the fluid is described using an advection-diffusion equation:
∂cj
∂t
+ (u · ∇)cj = Dj∇2cj, (3)
where cj (mol m−3) is the concentration of solute j and Dj (m2 s−1) is the diffusion coefficient
associated with solute j. We assume that each solute is present at a sufficiently low concen-
tration such that the presence of one solute has no impact on the transport of another (dilute
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assumption). We further assume no binding of solute j to components of the fluid (e.g. proteins)
but note that Dj may be adjusted to account for this process [15]. Initially, the solute concentra-
tion is zero (cj = 0) in the chamber. A constant supply of each solute (cj = cinj ) is prescribed
at the inlet and a convective flux (−n · Dj∇cj = 0, where n is an outward facing normal) is
imposed at the outlet. We assume the walls of the chamber are impermeable and impose a zero
flux condition of the form n · (−Dj∇cj + ucj) = 0 on all interior walls.
2.3 Solute reaction with the cells
We assume the cells are cultured at the base of the chamber either (i) within a 3D region of thick-
ness hc or (ii) as a monolayer. We further assume that the cells reside within media that does not
facilitate proliferation, which is common in many applications. For cases where cell prolifera-
tion is important, this may be incorporated following existing approaches in the literature (e.g.
[9–11]). To demonstrate how we may characterise different types of reaction between the solute
and the cells, we present two common reaction mechanisms. First, we consider a reaction gov-
erned by nonlinear saturable binding kinetics, suitable for describing the effect of a wide range
of drugs whose mode of action is governed by ligand-receptor interactions. Then, we consider
a reaction governed by Michaelis-Menten (M-M) kinetics, commonly used in the literature to
describe O2 consumption [5, 7, 8, 12–14] and paracetamol (APAP) metabolism [16, 17].
2.3.1 Reaction within a 3D cell region
Within the 3D cell region, there will be fluid flow in the interstitium between cells. This may be
modelled by considering the cell region as a porous medium and using Darcy’s Law to calculate
the flow field. However, the thinness of the cell region and the relatively low lateral pressure
differences and low permeability of the cell region, suggest that flow in the cell region will be
negligible. In instances in which interstitial flow is important, the reader is directed to [11] for
models that include this effect. We, therefore, describe solute transport using a reaction-diffusion
equation:
∂cj
∂t
= ∇ · (Dcellj ∇cj)−R3Dj , (4)
whereDcellj (m
2 s−1), the diffusivity tensor associated with solute j, is assumed to capture any
heterogeneity in cell distribution within the 3D region and, here, R3Dj (mol m
−3 s−1) describes
the bulk reaction between solute j and the cells. Initially, the solute concentration is zero (cj = 0)
in the cell region and we assume continuity of concentration and flux across the boundary.
2.3.2 Reaction within a monolayer
If we are interested in estimating only cell surface solute concentration profiles of a monolayer,
we may replace the 3D cell region with a flux boundary condition of the following form:
n · (−Dj∇cj + ucj) = R2Dj , (5)
where, here, R2Dj (mol m
−2 s−1) describes the surface reaction between solute j and the cells.
We note that (5) may also be used if we are interested in estimating solute concentrations on
the surface of a 3D region of cells (as in Section 2.3.1) in the special case of isotropic diffusion
within a sufficiently thin cell region.
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2.3.3 Reaction governed by nonlinear saturable binding kinetics
We describe the first type of reaction by nonlinear saturable binding:
R3Dj = k
f
j cj(Bj − bj)− krj bj, (6)
where cj (mol m−3) is the concentration of free drug, Bj (mol m−3) is the local density of
binding sites and kfj (mol
−1 m3 s−1) and krj (s
−1) are the forward and reverse reaction rates,
respectively. Here, we require an additional equation to track the concentration of bound drug,
bj (mol m−3), in the 3D cell region:
∂bj
∂t
= kfj cj(Bj − bj)− krj bj. (7)
We remark that nonlinear saturable irreversible binding and linear binding kinetics may be re-
covered as special cases of (7) through appropriate choice of the model parameters. We also
note that although we have chosen to model the binding process within a 3D cell region, these
equations may be easily adapted to describe the binding process via a flux boundary condition,
as in (5), by defining bj in units of mol m−2 and employing an appropriate mass conservation
condition.
2.3.4 Reaction governed by Michaelis-Menten kinetics
We describe the second type of solute reaction by M-M kinetics. These kinetics describe the
relationship between the concentration of solute and speed of a reaction: as solute concentration
increases, the reaction rate increases before approaching a maximum for higher solute concen-
trations [18, 19]. In this case, we have chosen to model the metabolic process using a flux
boundary condition but, again, these equations may be easily adapted to describe the metabolic
process within a 3D cell region by suitably adjusting the units of the model parameters. A
general M-M reaction term has the following form:
R2Dj =
m∑
i=1
V ij cj
Kij + cj
, (8)
where m is the number of metabolic pathways involved in the reaction, Kij (mol m
−3) is the
M-M constant for solute j and pathway i and V ij (mol m
−2 s−1) is the maximum reaction rate
for solute j and pathway i. It may be readily shown that
R2Dj ≈

m∑
i=1
V ij when
Kij
cj
 1
m∑
i=1
V ij cj
Kij
, when
Kij
cj
 1
, (9)
so that when the ratio of Kij to cj satisfies the above criteria, we can reasonably replace the full
M-M kinetics (8) by the approximate expressions (9).
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2.4 Derivation of relationships to inform experimental operating condi-
tions
For each type of reaction mechanism we provide simple relationships which allow for the rapid
prediction of steady-state solute concentrations, prior to experimentation.
2.4.1 Predicting steady-state solute concentrations when reaction is governed by nonlin-
ear saturable binding kinetics
Within the cell region, drug dynamics are typically characterised by a reaction rate consider-
ably faster than the time scale associated with diffusion [20], meaning that binding is usually
diffusion-limited. The implication is that bound and free drug coexist in a quasi-equilibrium
with bound drug concentrations given by
bj ≈ Bjcj
kdj + cj
. (10)
In such cases of rapid binding, it may readily be shown (see Supplementary Material) that in
the case of isotropic diffusion, we are able to reduce the nonlinear saturable binding model by
combining (4) and (7) to obtain an equation for the total drug concentration (Tj = cj + bj):
∂Tj
∂t
= ∇ · (D∗j∇Tj), D∗j ≈
Dcellj
1 +
Bjkdj
(kdj+cj)
2
, (11)
where D∗j is an effective concentration-dependent diffusion coefficient, k
d
j = k
r
j/k
f
j is the equi-
librium dissociation constant and
cj = −1
2
(kdj +Bj − Tj)±
1
2
√
(kdj +Bj − Tj)2 + 4kdjTj. (12)
For physically meaningful results, we require cj ≥ 0 so we consider only the positive root. It is
clear that the role of binding is accounted for through a reduced diffusion coefficient. In the limit
of rapid binding, the coupled time-dependent equations (4) and (7) may then be replaced with
the single partial differential equation (11) with bj obtained through the algebraic expression
(10). Expressing the model in terms of total drug concentration is often useful, since experi-
mental researchers often measure total drug concentrations (for reasons of convenience or due
to limitations of measurement protocols). Since no drug is lost from the system in this model (it
is either bound or unbound), at steady-state the free drug concentration should be equal to the
inlet concentration, i.e. cj = cinj , and thus we may use (10) to calculate the partitioning of drug
between cj and bj prior to experimentation. Note that since these expressions rely only on the
parameters kdj andBj , they may be used to calculate the steady-state concentrations for any drug
whose interaction with the cells is governed by nonlinear saturable binding kinetics, given that
the drug is supplied as a constant source and diffusion of drug within the cell region is isotropic.
2.4.2 Predicting steady-state cell surface solute concentrations when reaction is governed
by Michaelis-Menten kinetics
Since experiments can span over many days and it is often possible to connect multiple bioreac-
tor chambers together for high throughput testing, it would be useful to establish relationships
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between the inlet and cell surface concentrations in single and connected chambers so that cell
surface solute concentration profiles may be predicted a priori. When the solute reaction is
governed by M-M kinetics, the rate of metabolism is dependent on the solute concentration at
the cell surface i.e. metabolism is variable unless the cell surface solute concentration is uni-
form. However, if the solute concentration is high enough (cj  Kij), then from (9) the rate
of metabolism is approximately constant. In this case, if we vary only the inlet concentration,
cinj , then the shape of the cell surface solute concentration profile will stay approximately the
same since the fluid dynamics are unchanged and approximately the same amount of solute is
metabolised across the entire cell surface; however, the magnitude of the cell surface solute
concentration will vary according to the change in the inlet concentration. Thus, provided that
Rj ≈
∑m
i=1 V
i
j , if the cell surface concentration profile is known for a given c
in
j , we may predict
the cell surface concentration profile for any cin∗j via the following equation:
c∗j(y) ≈ cj(y) + ∆cinj , ∆cinj = cin
∗
j − cinj , (13)
where y is the axis through the centre of the cell surface from the inlet side to the outlet side of
the chamber. Here, c∗j(y) and cj(y) are the concentration profiles across the centre of the cell
surface corresponding to inlet concentrations of cin∗j and c
in
j , respectively. Note we have verified
that this equation may be generalised to predict the concentration profile across the entire surface
of the cells, but for simplicity we consider only the profile across the centre of the cell surface.
We can extend this idea to chambers connected in series: clearly, the solute concentration
will decrease from the first to the last chamber due to metabolism so it would be useful to es-
tablish a relationship between the cell surface solute concentration profiles in the first chamber
and in subsequent chambers. This would enable the prediction of the cell surface solute concen-
tration profile in chamber n based only on knowledge of the profile in chamber 1. Similarly to
(13), we have
cnj (y) ≈ c1j(y) + ∆cinj , ∆cinj = cin
n
j − cin
1
j ,
where cnj (y) is the unknown concentration profile across the centre of the cell surface in chamber
n, c1j(y) is the known concentration profile across the centre of the cell surface in chamber 1 and
∆cinj is the difference between the unknown inlet concentration in chamber n and the known
inlet concentration in chamber 1. Thus, in order to make use of this equation we need to be able
to estimate cinnj .
Let us first consider the concentration flux (mol s−1) entering and leaving chamber 1. At
steady-state, the concentration flux leaving the chamber via the outlet must be equal to the
concentration flux entering the chamber via the inlet minus the concentration flux at the cell
surface due to metabolism, i.e.∫
Aout
n · (−Dj∇c1out + u1outc1out) dAout = ∫
Ain
n · (−Dj∇c1in + u1inc1in) dAin
−
∫
Acells
m∑
i=1
V ij dAcells, (14)
where c1out and c
1
in (mol m
−3) are the concentrations at the outlet and the inlet faces of chamber
1, respectively, and Aout, Ain and Acells are the areas of the outlet face, the inlet face and the cell
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surface, respectively. Note that again we assume metabolism is approximately constant and for
convenience we define α =
∫
Acells
∑m
i=1 V
i
j dAcells.
Also at steady-state, the concentration flux leaving chamber 1 via the outlet must be equal to
the concentration flux entering chamber 2 via the inlet, i.e.∫
Aout
n · (−Dj∇c1out + u1outc1out) dAout = ∫
Ain
n · (−Dj∇c2in + u2inc2in) dAin, (15)
and combining (15) with (14) gives∫
Ain
n · (−Dj∇c2in + u2inc2in) dAin = ∫
Ain
n · (−Dj∇c1in + u1inc1in) dAin − α. (16)
We know that c1in is constant across Ain and if we also assume that c
2
in is constant then we have
−Dj∇c2in = −Dj∇c1in = 0.
We therefore neglect the diffusive flux at the inlets and this assumption will always be appropri-
ate when the system is convection-dominated. Then, from (16) we have
c2in
∫
Ain
u2in · n dAin = c1in
∫
Ain
u1in · n dAin − α,
and if we assume that the velocity profiles at the inlet to each chamber are identical then we
obtain:
c2in
∫
Ain
u1in · n dAin = c1in
∫
Ain
u1in · n dAin − α =⇒ c2in = c1in −
α∫
Ain
u1in · n dAin
= c1in −
α
Q
,
where Q (m3 s−1) is the input flow rate. Similarly, we have:
c3in = c
2
in −
α
Q
= c1in −
2α
Q
,
and for n chambers we obtain:
cnin = c
1
in −
(n− 1)α
Q
.
Thus, provided thatRj ≈
∑m
i=1 V
i
j , the cell surface concentration profile in chamber 1 is known,
the inlet concentrations are constant and the velocity profile at all inlets are the same, we may
predict the cell surface concentration profile in chamber n via the following equation:
cnj (y) ≈ c1j(y)−
(n− 1)α
Q
. (17)
As before, we have verified that this equation may be generalised to predict the concentration
profile across the entire surface of the cells, but for simplicity we consider only the profile across
the centre of the cell surface.
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2.5 Computational geometry
In order to demonstrate the utility of our model, we choose the geometry of a specific commer-
cial perfusion cell culture system which is gaining popularity: the QV900 (Fig. 2a) manufac-
tured by Kirkstall Ltd. (Rotherham, UK). The QV900 is a modular system comprising 6 cell
culture chambers that can be connected together in any combination. This allows experiments
to be performed either in parallel or in series, providing a high degree of flexibility as well as
the potential to culture cells over a defined set of conditions.
Initially, a computational 3D representation of a single chamber (Fig. 2b) was constructed.
The overall height of a single chamber ranges from 18.6 mm at the inlet side to 20.7 mm at the
outlet side. The diameter of the chamber is taken to be 16.0 mm, whilst the inner diameter of the
inlet and the outlet is 1.0 mm and 1.8 mm, respectively. The cells are assumed to be cultured at
the base of the chamber in either a 3D region of height hc or a monolayer.
We subsequently created a geometry to represent 6 chambers connected in series. Each
chamber is connected by a cylindrical tube of length 100 mm and diameter 2.4 mm. This is
representative of a typical connecting tube, although it is noted that there is a choice of various
tube lengths; however, we have verified that this feature does not significantly influence the
results since employing various tube lengths from 5−100 mm alters the results by approximately
1% or less.
(a) (b)
Figure 2: (a) The QV900. [www.kirkstall.org] (b) Idealised 3D geometry of a single QV900 chamber,
showing the orientation of the x, y and z axes where the origin is located at the centre of the base
(indicated by the red dot). Note that length scales are in m.
2.6 Parameter values
There are a number of parameters in the model that can be adjusted to represent different cell
culture conditions. Variable parameters such as input flow rate and inlet concentration are spec-
ified for each set of results and Table 1 presents the remaining parameters. For simplicity, the
values of ρ and µ are chosen under the assumption that the fluid is water; however, it is recog-
nised that these parameters may vary depending on the specific fluid used. Also note that for this
study we assume isotropic diffusion of solute within the 3D cell region and choose Dcellj = Dj ,
but we acknowledge that in reality these parameters may differ. To illustrate the results of our
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model, we choose representative parameters for three different solutes. For the reaction gov-
erned by nonlinear saturable binding, we describe the action of sirolimus (a drug with potent
anti-proliferative and immunosuppressive properties commonly used to coat arterial stents) on
smooth muscle cells. For the reaction goverened by M-M kinetics, we describe O2 consump-
tion for four different cell types (rat cardiomyocytes, human cardiomyocytes, rat hepatocytes
and HepG2 cells) and we describe APAP metabolism using parameters obtained from a study
performed in vivo in humans. Note that the maximum reaction rate for M-M kinetics is often
provided in varying units for different solutes; in order to balance the equations we need to either
multiply this parameter by the cell density or divide this parameter by the cell area for O2 and
APAP, respectively.
Parameter description Value Reference
Fluid parameters:
Density (ρ) 9.94× 102 kg m−3 [21]
Dynamic viscosity (µ) 6.89× 10−4 Pa s [21]
Diffusion coefficients:
Sirolimus (DS) 2.50× 10−10 m2 s−1 [22]
O2 (DO2 ) 3.00× 10−9 m2 s−1 [12]
APAP (DAPAP ) 6.00× 10−10 m2 s−1 [23]
Binding parameters for sirolimus:
Forward reaction rate (kfS) 2.00 mol
−1 m3 s−1 [22]
Reverse reaction rate (krS) 5.20× 10−3 s−1 [22]
Local density of binding sites (BS) 3.63× 10−1 mol m−3 [22]
Michaelis-Menten constants:
O2 (KO2 ) 6.60× 10−4 mol m−3 [12]
Glucuronidation (K1APAP ) 6.89 mol m
−3 [17]
Sulphation (K2APAP ) 9.70× 10−2 mol m−3 [17]
Oxidation (K3APAP ) 3.03× 10−1 mol m−3 [17]
MaximumO2 consumption rates:
Rat cardiomyocytes (VO2 ) 4.01× 10−8 mol m−2 s−1 [24]
Human cardiomyocytes (VO2 ) 9.81× 10−8 mol m−2 s−1 [24]
Rat hepatocytes (VO2 ) 2.39× 10−8 mol m−2 s−1 [25]
HepG2 cells (VO2 ) 1.17× 10−8 mol m−2 s−1 [25]
Maximum APAP metabolic rates:
Glucuronidation (V 1APAP ) 8.86× 10−2 mol m−2 s−1 [17]
Sulphation (V 2APAP ) 1.02× 10−3 mol m−2 s−1 [17]
Oxidation (V 3APAP ) 3.41× 10−4 mol m−2 s−1 [17]
General parameters:
Total number of cells (N ) 1.00× 105 this study
Volume of a smooth muscle cell (Vcell) 1.50× 10−14 m3 [26]
Area covered by the cells (A) 2.01× 10−4 m2 this study
Thickness of 3D cell region (hc = NVcell/A) 7.46× 10−6 m this study
Cell density (d = N/A) 4.97× 108 cells m−2 this study
Table 1: Parameter values.
2.7 Numerical implementation
Since the equations describing fluid flow are independent of solute concentration, we first solved
the fluid equations and then used this solution to subsequently solve the transport equations.
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The computational geometry was constructed and the finite element method was implemented
in COMSOL Multiphysics® 5.3 (Stockholm, Sweden). We note that a number of alternative
finite element codes may also be used to solve the model equations and boundary conditions
as detailed in Section 2. Since preliminary simulations showed that the solution to the problem
is symmetric about the y, z plane passing through the origin, we used symmetry of the geom-
etry to reduce the computational cost of the model so that only half of the problem was solved
numerically. The computational mesh was generated using the physics-controlled ‘extremely
fine’ setting. This choice was made based on a mesh sensitivity study where we established that
refinement of the mesh from the ‘extra fine’ setting to the ‘extremely fine’ setting resulted in less
than 1% change in the quantities of interest (mass conservation, shear stress and solute concen-
tration at the cell surface). This indicates that further refinement would have a negligible effect
on the results. The final mesh consisted of 2,152,947 tetrahedral elements with size ranging
from 0.03 to 0.46 mm and, where we modelled the cells as a 3D region, we generated a swept
triangular prism mesh in this domain. Note that we consider only the steady-state results since
our time-dependent simulations show that equilibrium is established relatively quickly. Specif-
ically, the flow reaches steady state rapidly for all flow rates considered (within 50 seconds)
while the time to steady state is more variable when solute transport is considered, ranging from
5-20 hours between the lowest and highest flow rates considered. The time to steady state was
assessed by quantitative comparison of fluid flow patterns, cell surface shear stresses, patterns of
solute concentrations and cell surface solute concentrations at different times. The model may,
of course, be used to generate time-dependent solutions if required.
3 Results
3.1 Fluid dynamics
We describe the velocity profile and cell surface shear stress in a single chamber for
Q = 100 − 1000 µL min−1, covering a realistic range of operating flow rates. As an exam-
ple, we display only the results for Q = 100 µL min−1 (Fig. 3) and the corresponding results
for the remaining flow rates can be found in the Supplementary Material. In this case, some
small zones of recirculation arise around the periphery at the base of the chamber and the peak
flow speed (4.20 × 10−3 m s−1) is located at the inlet. Given the considerable decrease in flow
speed with chamber depth, in Fig. 3b we use a log scale to plot the velocity magnitude in order
to better emphasise the variation in flow speed throughout the chamber. The magnitude of the
cell surface shear stress is of the order of 10−8 Pa and rises from all sides of the chamber towards
the peak (6.39× 10−8 Pa) located at the centre. As input flow rate is increased, the recirculation
zones increase in size and eventually merge to form one large zone which takes up the majority
of the chamber. The cell surface shear stress rises in magnitude with increasing input flow rate
and the profile changes most substantially betweenQ = 200 µL min−1 andQ = 500 µL min−1,
where the flow pattern transforms dramatically. We note that for chambers connected in series
there is no significant difference in the fluid dynamics in downstream chambers (not shown).
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(a) (b)
(c)
Figure 3: Simulation results for Q = 100 µL min−1. (a) Streamlines and magnitude of velocity through
the centre of the chamber on the y, z plane. (b) Magnitude of velocity through the centre of the chamber
on the y, z plane using a log scale. (c) Magnitude of shear stress at the cell surface on the x, y plane.
The peak cell surface flow speed and shear stress increase with input flow rate in a nonlinear
manner (Fig. 4). As input flow rate increases, the peak cell surface flow speed and shear stress
increase until around Q = 200 µL min−1 after which the profiles dip, reaching a minimum
at around Q = 300 µL min−1. After Q = 400 µL min−1 the peak cell surface flow speed
and shear stress increase rapidly with increasing input flow rate. We deduced that a significant
change in the pattern of flow is responsible for the dip: up to Q = 200 µL min−1 and after
Q = 500 µL min−1 the behaviour of the flow is relatively unchanging, whereas in between
we observe substantial differences in the appearance of the streamlines (most noticeably in the
merging of the recirculation zones) and cell surface shear stress profiles (see Supplementary
Material).
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(a) (b)
Figure 4: Relationship between input flow rate and peak cell surface flow speed (a) and shear stress (b)
with the inset plots illustrating each relationship up to Q = 400 µL min−1. Note that since the velocity
is equal to zero on the cell surface, we evaluate the ‘cell surface’ flow speed just above the cell surface at
z = hc.
3.2 Reaction governed by nonlinear saturable binding kinetics
We examine drug concentration profiles in the chamber for an input flow rate ofQ = 100 µL min−1
and a nominal inlet sirolimus concentration of cinS = 5.00 × 10−3 mol m−3. Our simulations
confirm (not shown) that at steady-state the free drug concentration profiles are uniform in the
chamber in line with our rationale described in Section 2.4.1. Furthermore, the bound drug
concentration within the cell layer takes the constant value bS = 0.2388 mol m−3, as predicted
from (10). The significance of this result is that since the steady-state concentration profiles are
uniform throughout, this implies the binding model is effectively a 1D problem which suggests
the geometry of the chamber and the flow profile within the chamber are irrelevant features. To
confirm this, we compared results between identical simulations using: (i) the QV900 geometry
versus a simple cylindrical geometry, and (ii) flow versus no flow. The results were identical
(data not shown).
3.3 Reaction governed by Michaelis-Menten kinetics
We examine solute concentration profiles in the chamber and at the cell surface for an input flow
rate of Q = 100 µL min−1. For the O2 profiles (Fig. 5), we show results for rat cardiomy-
ocytes as an example and we set cinO2 = 0.21 mol m
−3 to represent atmospheric O2 levels [12].
Corresponding results for the remaining cell types are detailed in the Supplementary Material.
The O2 concentration decreases from cinO2 = 0.21 mol m
−3 at the top of the chamber to approxi-
mately 0.07 mol m−3 at the base of the chamber. The cell surface O2 concentration ranges from
approximately 0.07 to 0.09 mol m−3.
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(a) (b)
Figure 5: Simulation results for rat cardiomyocytes withQ = 100 µL min−1 and cinO2 = 0.21 mol m
−3.
(a) O2 concentration profile through the centre of the chamber on the y, z plane. (b) O2 concentration at
the cell surface on the x, y plane
Similar trends are observed for the APAP profiles (Fig. 6). Here we show the results for
human liver cells with an inlet concentration of cinAPAP = 0.4 mol m
−3 to represent a dose of
60 mg/kg [17]. The APAP concentration decreases from cinAPAP = 0.4 mol m
−3 at the top of
the chamber to approximately 9.15 × 10−7 mol m−3 at the base of the chamber. The APAP
concentrations are very low at the cell surface, ranging from approximately 9.15 × 10−7 to
1.86× 10−6 mol m−3, suggesting that the majority of the APAP is metabolised by the cells.
(a) (b)
Figure 6: Simulation results for human liver cells withQ = 100 µL min−1 and cinAPAP = 0.4 mol m−3.
(a) APAP concentration profile through the centre of the chamber on the y, z plane. (b) APAP concentra-
tion at the cell surface on the x, y plane
In Fig. 7 we plot the average cell surface concentration versus flow rate for both O2 and
APAP. In the case of oxygen consumption we consider four cell types (rat cardiomyocytes,
human cardiomyocytes, rat hepatocytes and HepG2 cells), whilst for APAP we consider only
human liver cells due to the available data. The results of the simulations show that the average
cell surface concentration tends to increase as input flow rate increases across all cell types.
As with the profiles for the peak cell surface flow speed and shear stress, we observe a dip in
average cell surface concentration between Q = 200 µL min−1 and Q = 500 µL min−1 which
is explained by changes in the flow pattern.
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(a) (b)
Figure 7: Relationship between input flow rate and average cell surface O2 (a) and APAP (b). These
results correspond to input solute concentrations of cinO2 = 0.21 mol m
−3 and cinAPAP = 0.4 mol m
−3,
respectively.
Next, we test our hypotheses (13) and (17) which should allow for the prediction of the
solute concentration profiles at the cell surface in single and connected chambers, respectively.
Recall that these relationships inherently assume that the rate of metabolism is constant and
so only hold true for cj  Kij . For the parameters in Table 1, this criteria is not satisfied by
APAP and so we consider O2 as an example and illustrate the results for rat cardiomyocytes. In
Fig. 8a we compare our prediction of the cell surface O2 concentration profile from (13) to the
results of the simulation when we increase the inlet concentration from cinO2 = 0.21 mol m
−3 to
cinO2 = 0.3 mol m
−3, and excellent agreement is found. Integrating (13) with respect to y over
the diameter of the cell surface (−r < y < r) and rearranging gives
γ1 =
∫ r
−r c
∗
j(y) dy −
∫ r
−r cj(y) dy
2r∆cinj
≈ 1, (18)
where we have defined γ1 as a measure of how good the approximation (13) is. Therefore, to test
the validity of our hypothesis for predicting the cell surface solute concentration profile in a sin-
gle chamber when the inlet concentration is varied, we evaluated (18) for
Q = 100 µL min−1 and Q = 1000 µL min−1 with cinO2 = 0.21 mol m
−3. Fig. 8b demon-
strates that γ1 ≈ 1 for the majority of these cases, with the prediction improving for higher inlet
concentrations where cO2  KO2 and metabolism is approximately constant. The approxima-
tion is weakest for the lowest values of cinO2 where this criteria is not satisfied. Note that the
prediction is better for the higher flow rate: increasing input flow rate gives rise to higher cell
surface concentrations and so the assumption of cO2  KO2 is more accurate in this case.
In certain cases, it may be that the quantity of interest is the mean cell surface concentration,
rather than spatial profiles. We have demonstrated that our formula (13) extends to the case
of predicting mean concentrations (Fig. 8c and Fig. 8d). Moreover, we have established that
there is a linear relationship between the inlet O2 concentration and the mean cell surface O2
concentration for the majority of inlet O2 concentrations considered: the linear relationship
breaks down when cell surface O2 concentrations are sufficiently low that our approximation
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cO2  KO2 is no longer valid. We note from Fig. 8c and Fig. 8d that the approximation breaks
down at higher inlet O2 concentrations for the lower flow rate.
(a) (b)
(c) (d)
Figure 8: Single chamber predictions. (a) Comparison between our prediction using (13) (dashed line)
and the simulation (solid line) when we increase the inlet concentration from cinO2 = 0.21 mol m
−3
to cin
∗
O2
= 0.3 mol m−3. (b) Calculated γ1 values for Q = 100 and 1000 µL min−1 with cinO2 =
0.21 mol m−3. (c) Relationship between inlet O2 concentration and mean cell surface O2 concentration
for Q = 100 µL min−1. (d) Relationship between inlet O2 concentration and mean cell surface O2
concentration for Q = 1000 µL min−1.
To test the validity of our hypothesis for predicting the cell surface solute concentration pro-
file in chamber n given that the profile is known in chamber 1, we simulated the environment
in six connected chambers for Q = 100 µL min−1 and cinO2 = 0.21 mol m
−3. We then used
(17) to predict cnj (y). Fig. 9 compares the predictions (dashed lines) with the results obtained
from simulations (solid lines) for various input flow rates. The plots show that the predictions
improve with increasing input flow rate, since the assumption of constant metabolism is more
accurate. The deviation of the predicted values from the simulated concentrations is a combi-
nation of numerical error and the small errors associated with the assumptions that have been
made in deriving (17). We note that the difference between the predicted values and the sim-
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ulated concentrations in each chamber is less than 1% and this small deviation is, therefore,
considered to be acceptable. As with the single chamber predictions, our formula holds also for
mean cell surface concentrations and there is a linear relationship between mean cell surface O2
concentration and chamber number, provided that cO2  KO2 .
(a) (b)
(c) (d)
Figure 9: Connected chamber predictions for cinO2 = 0.21 mol m
−3, showing simulated (solid lines)
vs. predicted (dashed lines) cell surface O2 concentration profiles for (a) Q = 100 µL min−1 (b) Q =
300 µL min−1 (c) Q = 500 µL min−1 (d) Q = 700 µL min−1.
4 Discussion
Our findings have a number of important implications that should be considered carefully when
deciding on the operating conditions of perfusion cell culture systems.
Cell surface flow speed and shear stress critically depend on the choice of input flow rate
Varying the input flow rate over a realistic range of operating flow rates gives rise to qualitatively
different fluid dynamics within the chamber and strongly influences the cell surface flow speed
and shear stress levels. This means not only that the choice of flow rate is critical, but also that
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different flow rates should be chosen for different applications. For example, if one wishes to
test the response of cells to a drug where it is known that the cells are exposed to flow in vivo,
then the model presented here may be utilised to calculate the input flow rate that gives rise to
the desired cell surface flow speed. For some applications, it may be that the cells should be ex-
posed to slow-flow, while for other cell types it may be that higher flow speeds at the cell surface
are desired. Similarly, if it is known that a given cell type is capable of tolerating a known level
of shear stress, then again the model may be used to select a sensible flow rate that ensures cell
surface shear stress is kept within the desired range.
Spatial placement of cells influences the flow speed and shear stress that they experience
Fig. 3c shows clearly that there is a spatial distribution of shear stress at the cell surface. This
means that the choice of where cells are placed has an impact on the level of shear stress they
will experience. For example, in the case Fig. 3c, depending on the application, it may be
wise not to culture cells in the centre of the chamber, due to the peak in shear stress that occurs
there. The spatial distribution of shear stress changes with input flow rate (see Supplementary
Material), most substantially between Q = 200 − 500 µL min−1 as a result of the merging
recirculation zones. We remark that the non-monotonic behaviour of the flow speed and shear
stress with increasing input flow rate is not at all obvious and has only been identifiable through
the simulation approach considered here. For flow rates outside of this range the peak cell sur-
face shear stress is observed at the centre, whereas for flow rates within this range the pattern
is less predictable. Therefore, depending on the application it may well be wise to avoid these
flow rates. It is also important to note that the flow speed (and consequently the magnitude of
the shear stress) decreases as we move down the chamber (Fig. 3b). Therefore, one may also
change the flow environment the cells are exposed to by raising the position of the cells in the
chamber. The model presented here may therefore be used to optimise the spatial placement of
cells within the chamber.
Flow rate and Michaelis-Menten parameters dictate cell surface solute concentrations
Fig. 7 highlights that the cell surface solute concentration is strongly influenced by both flow
rate and the cell-specific M-M parameters. With the exception of the dip between Q = 200 −
500 µL min−1 (due to the change in fluid dynamics as described earlier), increasing the flow rate
corresponds to increasing the solute concentration that arrives at the cell surface and is available
for reaction. The variation in cell surface solute concentration across the different cell types
confirms that the M-M reaction at the cell surface also has an important influence on the cell
surface solute concentration. Relationships derived from the model, such as those in Fig. 7, can
therefore be utilised when configuring the input flow rate for experiments in which the desired
cell surface concentration is known.
Steady-state solute concentrations may be predicted a priori
In the case of reaction governed by nonlinear saturable binding kinetics, steady-state free and
bound solute concentrations within the cells may be calculated a priori using (10-12). Since
(10-12) rely only on the parameters kdj and Bj , they may be used to calculate the steady-state
concentrations for any drug whose interaction with the cells is governed by nonlinear saturable
binding kinetics, given that the drug is supplied as a constant source and diffusion of drug within
the cell region is isotropic. In the case of reaction governed by M-M kinetics, we have uncov-
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ered simple relationships between inlet solute concentrations and cell surface concentration in
single and connected chambers, provided that cj  Kj (Fig. 8 and Fig. 9). Our simple for-
mula (13) may be used to predict changes in cell surface solute concentrations when the inlet
solute concentration is altered, whilst (17) may be used to predict cell surface concentrations
in downstream chambers. These relationships could be extremely useful to help determine the
inlet concentration required to achieve a desired cell surface concentration, and moreover to de-
cide on a suitable number of chambers to connect before concentrations fall below some desired
level. Where possible, it is advisable to stay within the regime cj  Kj so that the results
remain predictable.
We feel it appropriate to reiterate that a number of assumptions have been made in this work,
as outlined in the preceding text. While the overall conclusions above are generally true, the
quantitative results provided in Section 3 are specific to the particular bioreactor that we have
simulated and must be interpreted within the context of the assumptions made. In particular,
we present results only for steady-state. Depending on the specific cell type and application, it
may be more appropriate to consider time-dependent solutions, for example, if the quantities of
interest need to be known in the very early stages of culture under flow. Our results are most
applicable when the steady-state (or ‘equilibrium’) conditions are of most interest.
5 Challenges
The focus of this paper has been on utilising modelling and simulation to help inform experi-
mental operating parameters. However, these two endeavours are, of course, intrinsically linked.
Mathematical and computational models require physical parameters (e.g. diffusion coefficients
and metabolism rates) and these are not always known to a great degree of accuracy. It is par-
ticularly common for parameters to be gleaned from a variety of data sets, where experiments
may not have been performed consistently, nor on the same type of cells or species. Sensitiv-
ity analysis may be used where there is some uncertainty over parameter values, but this has
limitations, especially when the model results are highly sensitive to changes in the unknown
parameters. Models, such as the one presented here, are most valuable when used in a predictive
sense. However, before one may gain confidence in the model predictions, it is crucial that the
model is validated. Therefore, it is critical that in silico tools are compared with experimental
data, even if such data is limited. This can be challenging for a number of reasons. For example,
it may not be easy (or possible) to take non-destructive measurements (e.g. cellular drug con-
centrations, O2 concentrations at the cell surface, spatially varying flow speeds) within certain
in vitro perfusion systems. Advanced imaging methods can help in this regard, but these may be
limited by the optical properties of the system at hand. Oxygen probes are available, but again,
these cannot easily be used without disrupting the experiments. We therefore strongly encour-
age the development of methods to acquire such data to facilitate model validation. Whilst the
difficulty of providing validation may be viewed as a disadvantage of modelling, it could also
be seen as an advantage, i.e., modelling can allow us to obtain insight into quantities that we
cannot easily measure experimentally.
The real value in modelling lies in the ability to reduce the number of experiments that have
to be performed. For example, even if a system has been experimentally characterised under a
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given set of operating parameters, it may not be obvious how the environment changes when
these operating parameters are altered. In this respect, a validated model can be invaluable, even
if the validation is performed over a limited set of conditions.
The issue of model verification is also highly pertinent in this field, i.e., ensuring the numer-
ical implementation of the model is correct. It is tempting to ‘believe’ results produced from
computational software. However, great care must be taken to ensure the correctness and accu-
racy of the results. In this sense, mesh sensitivity studies and common-sense checks are both
an integral part of computational modelling. However, these aspects are perhaps less familiar to
non-experts, underlining the critical role of computational modellers.
These challenges only emphasise the importance of interdisciplinarity in this exciting field
and that modelling and experimentation should go hand-in-hand, each complementing the other.
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